Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biochemistry ; 48(26): 6126-35, 2009 Jul 07.
Artigo em Inglês | MEDLINE | ID: mdl-19505151

RESUMO

The tumor suppressor protein p53 is a nuclear protein that serves as an important transcription factor. The region responsible for sequence-specific DNA interaction is located in its core domain (p53C). Although full-length p53 binds to DNA as a tetramer, p53C binds as a monomer since it lacks the oligomerization domain. It has been previously demonstrated that two core domains have a dimerization interface and undergo conformational change when bound to DNA. Here we demonstrate that the interaction with a consensus DNA sequence provides the core domain of p53 with enhanced conformational stability at physiological salt concentrations (0.15 M). This stability could be either increased or abolished at low (0.01 M) or high (0.3 M) salt concentrations, respectively. In addition, interaction with the cognate sequence prevents aggregation of p53C into an amyloid-like structure, whereas binding to a nonconsensus DNA sequence has no effect on p53C stability, even at low ionic strength. Strikingly, sequence-specific DNA binding also resulted in a large stabilization of full-length p53, whereas nonspecific sequence binding led to no stabilization. The effects of cognate DNA could be mimicked by high concentrations of osmolytes such as glycerol, which implies that the stabilization is caused by the exclusion of water. Taken together, our results show an enhancement in protein stability driven by specific DNA recognition. When cognate DNA was added to misfolded protein obtained after a pressurization cycle, the original conformation was mostly recovered. Our results may aid the development of therapeutic approaches to prevent misfolded species of p53.


Assuntos
DNA/farmacologia , Dobramento de Proteína/efeitos dos fármacos , Proteína Supressora de Tumor p53/química , Proteína Supressora de Tumor p53/metabolismo , Naftalenossulfonato de Anilina/química , Sequência Consenso , DNA/metabolismo , Corantes Fluorescentes/química , Glicerol/química , Humanos , Pressão Hidrostática , Luz , Concentração Osmolar , Polidesoxirribonucleotídeos/química , Polidesoxirribonucleotídeos/metabolismo , Ligação Proteica/genética , Conformação Proteica/efeitos dos fármacos , Desnaturação Proteica , Estabilidade Proteica/efeitos dos fármacos , Proteínas Recombinantes/química , Espalhamento de Radiação , Espectrometria de Fluorescência , Proteína Supressora de Tumor p53/genética , Água/química
2.
J Enzyme Inhib ; 8(4): 261-5, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-7542323

RESUMO

Several homologous polynucleotides have been tested as inhibitors on the reactions catalyzed by avian myeloblastosis virus (AMV) reverse transcriptase, in the presence of polyribonucleotides and 2'-fluorinated polynucleotides as templates. Polynucleotides differentially inhibited the reactions catalyzed by reverse transcriptase in the presence of these synthetic templates. Polyriboadenylic acid (poly(rA), poly(2'-O-methyladenylic acid) (poly(Am)), poly(2'-fluoro-2'-deoxyadenylic acid) (poly(dAfl), polyinosinic acid (poly(rI)) and polyuridylic acid poly(rU)) inhibited the polyribonucleotide-, but not the 2'-fluorinated polynucleotide-directed reverse transcriptase activity.


Assuntos
DNA/biossíntese , Polidesoxirribonucleotídeos/metabolismo , Polinucleotídeos/farmacologia , Polirribonucleotídeos/metabolismo , DNA Polimerase Dirigida por RNA/metabolismo , Vírus da Mieloblastose Aviária/enzimologia , Relação Dose-Resposta a Droga , Flúor/farmacologia , Manganês/farmacologia , Poli A/farmacologia , Poli I/farmacologia , Poli U/farmacologia , Inibidores da Transcriptase Reversa , Moldes Genéticos
3.
J Enzyme Inhib ; 9(2): 171-7, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8583254

RESUMO

Some intercalating and nonintercalating drugs have been tested as inhibitors on the DNA synthesis reaction catalyzed by avian myeloblastosis virus (AMV) reverse transcriptase, in the presence of polyriboadenylic acid (poly(rA)) and poly(2'-fluoro-2'-deoxyadenylic acid) (poly(dAfl)) as templates. In both cases, the inhibition was higher with the intercalating drug ethidium bromide than with the nonintercalating analog tetramethyl ethidium bromide. Ethidium bromide inhibited more efficiently the poly(rA)- than the poly(dAfl)-directed reverse transcriptase reaction; in the latter case, the inhibition was non-competitive in relation to TTP. On the other hand, the reaction catalyzed in the presence of the 2'-fluorinated polynucleotide as template was inhibited to a higher extent by other nonintercalating drugs, berenil, netropsin, and distamycin. The inhibitions of both reactions by dideoxy TTP, novobiocin and HPA-23 are also discussed.


Assuntos
Inibidores Enzimáticos/farmacologia , Substâncias Intercalantes/farmacologia , Poli A/metabolismo , Polidesoxirribonucleotídeos/metabolismo , Inibidores da Transcriptase Reversa/farmacologia , DNA/biossíntese , DNA Polimerase Dirigida por RNA/metabolismo , Moldes Genéticos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA